New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - modified release tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25 mg/ml;   - solution for injection - 75mg/3ml - active: diclofenac sodium 25 mg/ml   excipient: benzyl alcohol mannitol propylene glycol sodium hydroxide sodium metabisulfite water for injection - treatment of biliary colic.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 100mg;   - suppository - 100 mg - active: diclofenac sodium 100mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 12.5mg;   - suppository - 12.5 mg - active: diclofenac sodium 12.5mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;   - suppository - 25 mg - active: diclofenac sodium 25mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 50mg;   - suppository - 50 mg - active: diclofenac sodium 50mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 100mg;  ;   - modified release tablet - 100 mg - active: diclofenac sodium 100mg     excipient: cetyl alcohol colloidal silicon dioxide hypromellose iron oxide red magnesium stearate opacode black s-1-17823 polysorbate 80 povidone purified talc sucrose titanium dioxide - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 75mg;  ;   - modified release tablet - 75 mg - active: diclofenac sodium 75mg     excipient: cetyl alcohol colloidal silicon dioxide hypromellose pigment suspension, white pigment suspension, red macrogol 8000 magnesium stearate opacode black s-1-17823 polysorbate 80 povidone purified talc sucrose - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - isosorbide mononitrate 40mg;   - modified release tablet - 40 mg - active: isosorbide mononitrate 40mg   excipient: colloidal silicon dioxide hydrated silica hypromellose lactose monohydrate macrogol 4000 magnesium stearate polyvidone 30 - corangin is indicated for: · prevention of angina pectoris attacks, and also in cases where symptoms of angina pectoris persist after myocardial infarction. corangin may be used either as monotherapy or in combination with other antianginal agents (e.g. beta-blockers or calcium antagonists).

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - isosorbide mononitrate 60mg;   - modified release tablet - 60 mg - active: isosorbide mononitrate 60mg   excipient: colloidal silicon dioxide hydrated silica hypromellose lactose monohydrate macrogol 4000 magnesium stearate polyvidone 30 - corangin is indicated for: · prevention of angina pectoris attacks, and also in cases where symptoms of angina pectoris persist after myocardial infarction. corangin may be used either as monotherapy or in combination with other antianginal agents (e.g. beta-blockers or calcium antagonists).